GlassScriptPhysician profile
James D Alderman
NPI 1457342065
$2,402.92
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $142 · 2021: $650 · 2022: $950.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $577.17 | 2019-2022 | |
| Amgen INC. | $219.16 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $216.55 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $208.12 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $172.70 | 2019-2022 | |
| Esperion Therapeutics, INC. | $124.99 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $118.64 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $108.64 | 2021-2022 | |
| Pfizer INC. | $93.29 | 2019-2021 | |
| Biotronik INC. | $75.36 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.26 | 2021-2022 | |
| Amarin Pharma, INC. | $71.75 | 2019-2020 | |
| Medtronic, INC. | $61.29 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $54.12 | 2022 | |
| Novo Nordisk INC | $46.98 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.35 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $38.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.58 | 2019-2020 | |
| Philips North America LLC | $22.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.48 | 2022 | |
| Chiesi USA, INC. | $11.24 | 2020 | |
| Terumo Medical Corporation | $11.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Alderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.